Indication
Healthy Adult
5 clinical trials
8 products
Clinical trial
An Open-label, Randomized, Single Administration, Full Replicated Crossover Phase 1 Clinical Trial to Compare Pharmacokinetics and Safety Between JLP-1901 and JC-001 in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-03-11
Product
JC-001Product
JLP-1901Clinical trial
A Phase 1 Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-11-08
Clinical trial
A Randomized, Open-label, Two-sequence, and Two-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between the Administration of JLP-2008 and the Co-admin. of JT-001, and JT-002 for Healthy Subjects in Fasted StateStatus: Completed, Estimated PCD: 2022-06-13
Product
JC-013Product
SGLT2 inhibitorProduct
JLP-2004Clinical trial
Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JMKX003142 Injection Administered Randomly, Double-blind, Placebo-controlled, Single-ascending Dose and Multiple-ascending Doses in Chinese Healthy Adult SubjectsStatus: Not yet recruiting, Estimated PCD: 2025-01-31
Product
PlaceboProduct
JMKX003142Product
SON-1010Clinical trial
A Phase 1, Randomized, Adaptive-Design, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SON-1010 (IL12-FHAB) in Healthy AdultsStatus: Completed, Estimated PCD: 2023-02-28